Patient characteristics
| Age (years) | 64 ± 4 |
| Male | 8 (62%) |
| Platelet (×106/mL) | 328 ± 34 |
| White blood cell (×106/mL) | 8 ± 1 |
| C-reactive protein (mg/L) | 27 ± 7 |
| Diagnosis | |
| Metastatic ovarian cancer, stage IV | 2 (15%) |
| Metastatic pancreatic cancer, stage IV | 2 (15%) |
| Metastatic breast cancer, stage IV | 2 (15%) |
| Metastatic lung cancer, stage IV | 1 (8%) |
| Metastatic colorectal cancer, stage IV | 1 (8%) |
| Metastatic melanoma, stage IV | 1 (8%) |
| Metastatic chondrosarcoma, stage IV | 1 (8%) |
| Advanced gastric cancer, stage IV | 1 (8%) |
| Recurrent esophageal cancer, stage IV | 1 (8%) |
| Glioblastoma multiforme, stage IV | 1 (8%) |
| Medications | |
| Aspirin | 2 (15%) |
| Anticoagulant | 5 (39%) |
| Paracetamol | 4 (31%) |
| Beta-blocker | 3 (23%) |
| Calcium channel blocker | 2 (15%) |
| Oral nitrate | 1 (8%) |
| Angiotensin-converting enzyme inhibitor | 1 (8%) |
| Cardiac glycoside | 1 (8%) |
| Angiotensin II receptor antagonist | 1 (8%) |
| Statin | 2 (15%) |
| Loop diuretic | 2 (15%) |
| Opiate | 8 (62%) |
| Glucocorticosteroid | 4 (31%) |
| Proton pump inhibitor | 8 (62%) |
| Selective serotonin reuptake inhibitor | 3 (23%) |
| Antibiotic | 4 (31%) |
Data are presented as mean value ± SEM or number (%) of patients. Information on C-reactive protein was available for 10 patients.